By proceeding, you agree to our Terms of Use and Privacy Policy.
The 2nd Fc Receptor & IgG Targeted Therapies Summit is your definitive meeting for the most up-to-date clinical and commercial developments on pioneering strategies to modulate FcRs and harness their full therapeutic potential.
Access exclusive data on targeting FcRn and FcyRs. Learn about the engineering strategies that utilize the FcR-IgG interaction to deliver clinical efficacy.
Gain insights on innovative drug design, the current state of play of FcR antagonists, Fc fusion proteins and next-gen engineering strategies.
Connect with industry leaders such as FDA, Genentech, Alexion, UCB, Argenx, Genmab, and learn how they are modulating the strong behavior of IgG.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research.
Cancer. Diabetes. Alzheimer’s. Heart Disease. Parkinson’s. The Jackson Laboratory (JAX) leads the search to cure diseases rooted in our DNA.
Biointron is a leading high throughput recombinant antibody/protein expression provider. From gene sequence to purified antibodies, it just takes 2 weeks.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.